Clinical Therapeutics in Hong Kong
Hong Kong is a compact territory in Southern China that enjoys a high degree of autonomy. Despite its dense population and uneven wealth distribution, infant mortality is low and life expectancy is long. The health service is more hospital and clinic based than community based. This seems cost-effec...
Gespeichert in:
| Veröffentlicht in: | Clinical therapeutics 2019-03, Vol.41 (3), p.592-597 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 597 |
|---|---|
| container_issue | 3 |
| container_start_page | 592 |
| container_title | Clinical therapeutics |
| container_volume | 41 |
| creator | Cheung, Bernard M.Y. Yau, Henry K.C. |
| description | Hong Kong is a compact territory in Southern China that enjoys a high degree of autonomy. Despite its dense population and uneven wealth distribution, infant mortality is low and life expectancy is long. The health service is more hospital and clinic based than community based. This seems cost-effective while professional standards are high and rigorously maintained. Drug registration follows American and European requirements. Hong Kong is a part of the Pharmaceutical Inspection Cooperation Scheme, which brings a high standard of drug regulation. Hong Kong is a good choice for clinical trials because the subjects are Chinese and protocols in English do not need to be translated. There are also 2 well-established clinical trials centers in university hospitals that also run Phase I and clinical pharmacology studies. |
| doi_str_mv | 10.1016/j.clinthera.2019.01.002 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7172533</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0149291819300062</els_id><sourcerecordid>2179540869</sourcerecordid><originalsourceid>FETCH-LOGICAL-c449t-f9929634cc1a9e9e2364f7bd3f5c766b5b0a7d5d246fb6557114933adf5ff5853</originalsourceid><addsrcrecordid>eNqFkUtPAyEUhYnRaH38BW1042ZGLgxQNiZN4yuauKmJO8IwUGmmMxVmmvjvpak26sYNLPju4dxzEDoDnAMGfjXPTe2b7s0GnRMMMseQY0x20ABGQmYAxesuGmAoZEYkjA7QYYxzjDGVjOyjA4oFlhxggM4nSccbXQ-na7Gl7Ttv4tA3w_u2mQ0f03GM9pyuoz35uo_Qy-3NdHKfPT3fPUzGT5kpCtllTkoiOS2MAS2ttITywomyoo4ZwXnJSqxFxSpScFdyxkQyKSnVlWPOsRGjR-h6o7vsy4WtjG26oGu1DH6hw4dqtVe_Xxr_pmbtSgkQhFGaBC6_BEL73tvYqYWPxta1bmzbR0VASFbgEZcJvfiDzts-NGm9RMmUWGLXjsSGMqGNMVi3NQNYrXtQc7XtQa17UBhU6iFNnv7cZTv3HXwCxhvApkRX3gYVjbeNsZUP1nSqav2_n3wC7zGcVQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2199182175</pqid></control><display><type>article</type><title>Clinical Therapeutics in Hong Kong</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>ProQuest Central UK/Ireland</source><creator>Cheung, Bernard M.Y. ; Yau, Henry K.C.</creator><creatorcontrib>Cheung, Bernard M.Y. ; Yau, Henry K.C.</creatorcontrib><description>Hong Kong is a compact territory in Southern China that enjoys a high degree of autonomy. Despite its dense population and uneven wealth distribution, infant mortality is low and life expectancy is long. The health service is more hospital and clinic based than community based. This seems cost-effective while professional standards are high and rigorously maintained. Drug registration follows American and European requirements. Hong Kong is a part of the Pharmaceutical Inspection Cooperation Scheme, which brings a high standard of drug regulation. Hong Kong is a good choice for clinical trials because the subjects are Chinese and protocols in English do not need to be translated. There are also 2 well-established clinical trials centers in university hospitals that also run Phase I and clinical pharmacology studies.</description><identifier>ISSN: 0149-2918</identifier><identifier>EISSN: 1879-114X</identifier><identifier>DOI: 10.1016/j.clinthera.2019.01.002</identifier><identifier>PMID: 30709611</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Autonomy ; Clinical trials ; Clinical Trials as Topic ; Councils ; Drug Approval ; Education ; Ethics ; FDA approval ; Foreign trade zones ; Free trade ; GDP ; Gross Domestic Product ; Health care industry ; Health services ; Health Services - standards ; Hong Kong ; Hospitals ; Humans ; Infant mortality ; Inspection ; International organizations ; Licensing examinations ; Life expectancy ; Life span ; Medical research ; Medical schools ; Pharmaceutical inspection cooperation scheme ; Pharmacology ; Pharmacology, Clinical ; Population ; Professional standards ; Quality of Health Care ; Registration ; Sales taxes ; Territory ; Therapeutics</subject><ispartof>Clinical therapeutics, 2019-03, Vol.41 (3), p.592-597</ispartof><rights>2019 Elsevier Inc.</rights><rights>Copyright © 2019 Elsevier Inc. All rights reserved.</rights><rights>2019. Elsevier Inc.</rights><rights>2019 Elsevier Inc. All rights reserved. 2019 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c449t-f9929634cc1a9e9e2364f7bd3f5c766b5b0a7d5d246fb6557114933adf5ff5853</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2199182175?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>230,315,781,785,886,3551,27929,27930,46000,64390,64392,64394,72474</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30709611$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cheung, Bernard M.Y.</creatorcontrib><creatorcontrib>Yau, Henry K.C.</creatorcontrib><title>Clinical Therapeutics in Hong Kong</title><title>Clinical therapeutics</title><addtitle>Clin Ther</addtitle><description>Hong Kong is a compact territory in Southern China that enjoys a high degree of autonomy. Despite its dense population and uneven wealth distribution, infant mortality is low and life expectancy is long. The health service is more hospital and clinic based than community based. This seems cost-effective while professional standards are high and rigorously maintained. Drug registration follows American and European requirements. Hong Kong is a part of the Pharmaceutical Inspection Cooperation Scheme, which brings a high standard of drug regulation. Hong Kong is a good choice for clinical trials because the subjects are Chinese and protocols in English do not need to be translated. There are also 2 well-established clinical trials centers in university hospitals that also run Phase I and clinical pharmacology studies.</description><subject>Autonomy</subject><subject>Clinical trials</subject><subject>Clinical Trials as Topic</subject><subject>Councils</subject><subject>Drug Approval</subject><subject>Education</subject><subject>Ethics</subject><subject>FDA approval</subject><subject>Foreign trade zones</subject><subject>Free trade</subject><subject>GDP</subject><subject>Gross Domestic Product</subject><subject>Health care industry</subject><subject>Health services</subject><subject>Health Services - standards</subject><subject>Hong Kong</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Infant mortality</subject><subject>Inspection</subject><subject>International organizations</subject><subject>Licensing examinations</subject><subject>Life expectancy</subject><subject>Life span</subject><subject>Medical research</subject><subject>Medical schools</subject><subject>Pharmaceutical inspection cooperation scheme</subject><subject>Pharmacology</subject><subject>Pharmacology, Clinical</subject><subject>Population</subject><subject>Professional standards</subject><subject>Quality of Health Care</subject><subject>Registration</subject><subject>Sales taxes</subject><subject>Territory</subject><subject>Therapeutics</subject><issn>0149-2918</issn><issn>1879-114X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkUtPAyEUhYnRaH38BW1042ZGLgxQNiZN4yuauKmJO8IwUGmmMxVmmvjvpak26sYNLPju4dxzEDoDnAMGfjXPTe2b7s0GnRMMMseQY0x20ABGQmYAxesuGmAoZEYkjA7QYYxzjDGVjOyjA4oFlhxggM4nSccbXQ-na7Gl7Ttv4tA3w_u2mQ0f03GM9pyuoz35uo_Qy-3NdHKfPT3fPUzGT5kpCtllTkoiOS2MAS2ttITywomyoo4ZwXnJSqxFxSpScFdyxkQyKSnVlWPOsRGjR-h6o7vsy4WtjG26oGu1DH6hw4dqtVe_Xxr_pmbtSgkQhFGaBC6_BEL73tvYqYWPxta1bmzbR0VASFbgEZcJvfiDzts-NGm9RMmUWGLXjsSGMqGNMVi3NQNYrXtQc7XtQa17UBhU6iFNnv7cZTv3HXwCxhvApkRX3gYVjbeNsZUP1nSqav2_n3wC7zGcVQ</recordid><startdate>20190301</startdate><enddate>20190301</enddate><creator>Cheung, Bernard M.Y.</creator><creator>Yau, Henry K.C.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20190301</creationdate><title>Clinical Therapeutics in Hong Kong</title><author>Cheung, Bernard M.Y. ; Yau, Henry K.C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c449t-f9929634cc1a9e9e2364f7bd3f5c766b5b0a7d5d246fb6557114933adf5ff5853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Autonomy</topic><topic>Clinical trials</topic><topic>Clinical Trials as Topic</topic><topic>Councils</topic><topic>Drug Approval</topic><topic>Education</topic><topic>Ethics</topic><topic>FDA approval</topic><topic>Foreign trade zones</topic><topic>Free trade</topic><topic>GDP</topic><topic>Gross Domestic Product</topic><topic>Health care industry</topic><topic>Health services</topic><topic>Health Services - standards</topic><topic>Hong Kong</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Infant mortality</topic><topic>Inspection</topic><topic>International organizations</topic><topic>Licensing examinations</topic><topic>Life expectancy</topic><topic>Life span</topic><topic>Medical research</topic><topic>Medical schools</topic><topic>Pharmaceutical inspection cooperation scheme</topic><topic>Pharmacology</topic><topic>Pharmacology, Clinical</topic><topic>Population</topic><topic>Professional standards</topic><topic>Quality of Health Care</topic><topic>Registration</topic><topic>Sales taxes</topic><topic>Territory</topic><topic>Therapeutics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cheung, Bernard M.Y.</creatorcontrib><creatorcontrib>Yau, Henry K.C.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest Healthcare Administration Database</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest research library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cheung, Bernard M.Y.</au><au>Yau, Henry K.C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical Therapeutics in Hong Kong</atitle><jtitle>Clinical therapeutics</jtitle><addtitle>Clin Ther</addtitle><date>2019-03-01</date><risdate>2019</risdate><volume>41</volume><issue>3</issue><spage>592</spage><epage>597</epage><pages>592-597</pages><issn>0149-2918</issn><eissn>1879-114X</eissn><abstract>Hong Kong is a compact territory in Southern China that enjoys a high degree of autonomy. Despite its dense population and uneven wealth distribution, infant mortality is low and life expectancy is long. The health service is more hospital and clinic based than community based. This seems cost-effective while professional standards are high and rigorously maintained. Drug registration follows American and European requirements. Hong Kong is a part of the Pharmaceutical Inspection Cooperation Scheme, which brings a high standard of drug regulation. Hong Kong is a good choice for clinical trials because the subjects are Chinese and protocols in English do not need to be translated. There are also 2 well-established clinical trials centers in university hospitals that also run Phase I and clinical pharmacology studies.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>30709611</pmid><doi>10.1016/j.clinthera.2019.01.002</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0149-2918 |
| ispartof | Clinical therapeutics, 2019-03, Vol.41 (3), p.592-597 |
| issn | 0149-2918 1879-114X |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7172533 |
| source | MEDLINE; Access via ScienceDirect (Elsevier); ProQuest Central UK/Ireland |
| subjects | Autonomy Clinical trials Clinical Trials as Topic Councils Drug Approval Education Ethics FDA approval Foreign trade zones Free trade GDP Gross Domestic Product Health care industry Health services Health Services - standards Hong Kong Hospitals Humans Infant mortality Inspection International organizations Licensing examinations Life expectancy Life span Medical research Medical schools Pharmaceutical inspection cooperation scheme Pharmacology Pharmacology, Clinical Population Professional standards Quality of Health Care Registration Sales taxes Territory Therapeutics |
| title | Clinical Therapeutics in Hong Kong |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T22%3A08%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20Therapeutics%20in%20Hong%20Kong&rft.jtitle=Clinical%20therapeutics&rft.au=Cheung,%20Bernard%20M.Y.&rft.date=2019-03-01&rft.volume=41&rft.issue=3&rft.spage=592&rft.epage=597&rft.pages=592-597&rft.issn=0149-2918&rft.eissn=1879-114X&rft_id=info:doi/10.1016/j.clinthera.2019.01.002&rft_dat=%3Cproquest_pubme%3E2179540869%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2199182175&rft_id=info:pmid/30709611&rft_els_id=S0149291819300062&rfr_iscdi=true |